Telix Completes Acquisition of Next-Generation Therapeutic Assets
February 3, 2025
Telix Pharmaceuticals Limited, announces it has completed the acquisition from antibody engineering company ImaginAb, (ImaginAb). The acquisition includes a pipeline of next-generation therapeutic candidates, a